Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 35

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-1)

Sum=0

Sep 21, 2024 (publication date) through Sep 13, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Sep 21, 2024; 30(35): 3942-3953
Published online Sep 21, 2024. doi: 10.3748/wjg.v30.i35.3942

Full Size Figure Download Figure

Figure 2 Most frequent adverse events related to Janus kinase inhibitors and how to manage them.

Citation: Caballero-Mateos AM, Cañadas-de la Fuente GA. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World J Gastroenterol 2024; 30(35): 3942-3953
URL: https://www.wjgnet.com/1007-9327/full/v30/i35/3942.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i35.3942